轻度头部损伤且正在服用直接口服抗凝药的成人是否应接受CT扫描?一项系统评价
该系统评价纳入7项队列研究、共346例格拉斯哥昏迷评分13~15分且正在服用直接口服抗凝药的轻度头部损伤成人,评估不良结局(死亡、颅内血肿或神经外科手术)风险。随机效应Meta分析显示加权复合结局风险为3.7%(95%CI 1.7%~5.8%;I²=3.3%),各研究估计范围0.0%~8.3%。所有研究存在高或不明确的偏倚风险,总体证据质量低(因不精确性、间接性和偏倚风险)。作者结论认为现有数据有限,需足够效能的前瞻性队列研究来定义该风险并指导未来指南。
要点
- 服用直接口服抗凝药的轻度头部损伤(GCS 13~15分)成人,不良结局(死亡、颅内血肿或神经外科手术)汇总风险为3.7%(95%CI 1.7%~5.8%)。
- 7项队列研究共346例患者,各研究不良结局估计范围0.0%~8.3%,异质性I²=3.3%。
- 所有纳入研究因选择偏倚和信息偏倚存在高或不明确的偏倚风险,总体证据质量低。
- 作者认为现有数据有限,需足够效能的前瞻性队列研究来有效定义该风险并识别预测不良结局的临床特征。
适用人群与场景
- 成人轻度头部损伤患者,格拉斯哥昏迷评分13~15分,且正在服用直接口服抗凝药。
诊断标准与关键阈值
- 轻度头部损伤定义为格拉斯哥昏迷评分13~15分。
- 不良结局复合终点包括任何死亡、颅内血肿或神经外科手术。
研究设计与关键结果
- 系统评价共筛选4886篇文章,最终纳入7项队列研究、346例患者。
- 不良结局(任何死亡、颅内血肿或神经外科手术)估计范围0.0%~8.3%。
- 随机效应Meta分析显示加权复合结局风险为3.7%(95%CI 1.7%~5.8%;I²=3.3%)。
- 所有研究因选择偏倚和信息偏倚存在高或不明确的偏倚风险。
- 总体证据质量低,原因包括不精确性、间接性和偏倚风险。
证据类型、等级与局限
- 证据类型:系统评价与随机效应Meta分析,纳入7项队列研究。
- 总体证据质量按GRADE方法评估为低。
- 局限:所有研究存在高或不明确的偏倚风险(选择偏倚和信息偏倚);总体证据质量低(不精确性、间接性和偏倚风险);作者结论指出现有数据有限,需足够效能的前瞻性队列研究来有效定义风险、识别预测不良结局的临床特征并指导未来头部损伤指南。
对床旁实践的改变
- 作者认为现有数据有限,不足以刻画服用直接口服抗凝药的轻度创伤性脑损伤患者的不良结局风险,需足够效能的前瞻性队列研究来有效定义该风险、识别预测不良结局的临床特征并指导未来头部损伤指南。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: Patients receiving direct oral anticoagulant medications commonly undergo computed tomography head scanning after mild traumatic brain injury, regardless of symptoms or signs. International guidelines have noted a lack of evidence to support management decisions for such patients. This systematic review aims to identify, appraise, and synthesize the current evidence for the risk of adverse outcome in patients receiving direct oral anticoagulants after mild head injury.
METHODS: A protocol was registered with PROSPERO and review methodology followed Cochrane Collaboration recommendations. Studies of adult patients with mild head injury (Glasgow Coma Scale score 13 to 15) and who were receiving direct oral anticoagulants that reported the risk of adverse outcome after the head injury were eligible for inclusion. A comprehensive range of bibliographic databases and gray literature was examined with a sensitive search strategy. Selection of eligible studies, data extraction, and risk of bias were evaluated independently by separate reviewers. A random-effects meta-analysis was used to provide a pooled estimate of the risk of adverse outcome. The overall quality of evidence was assessed with the Grading of Recommendations Assessment, Development and Evaluation Working Group approach.
RESULTS: A total of 4,886 articles were screened for inclusion, of which 7 cohort studies including 346 patients met inclusion criteria. All studies were at high or unclear risk of bias as a result of selection and information bias. Estimates of adverse outcome (any death, intracranial hematoma, or neurosurgery) ranged from 0.0% to 8.3%. A random-effects meta-analysis showed a weighted composite outcome risk of 3.7% (95% confidence interval 1.7% to 5.8%; I2=3.3%). The overall quality of the body of evidence was low as a result of imprecision, indirectness, and risk of bias.
CONCLUSION: There are limited data available to characterize the risk of adverse outcome in patients receiving direct oral anticoagulants after mild traumatic brain injury. A sufficiently powered prospective cohort study is required to validly define this risk, identify clinical features predictive of adverse outcome, and inform future head injury guidelines.
参考来源
- Fuller GW, Evans R, Preston L, et al. Should Adults With Mild Head Injury Who Are Receiving Direct Oral Anticoagulants Undergo Computed Tomography Scanning? A Systematic Review. Ann Emerg Med. 2018. PMID: 30236417. doi:10.1016/j.annemergmed.2018.07.020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。